Phytoscience Herbal Api Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 64.30%
(FY 2022)
- Ebitda 22.34%
(FY 2022)
- Net Worth -28.21%
(FY 2022)
- Total Assets 7.22%
(FY 2022)
About Phytoscience Herbal Api
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hemaliben Shah, Gaurang Shah, and Kalpeshkumar Shah serve as directors at the Company.
- CIN/LLPIN
U24110GJ2019PTC106507
- Company No.
106507
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Phytoscience Herbal Api?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemaliben Shah  | Director | 09-Feb-2019 | Current |
| Gaurang Shah | Director | 09-Feb-2019 | Current |
| Kalpeshkumar Shah | Director | 09-Feb-2019 | Current |
Financial Performance of Phytoscience Herbal Api.
Phytoscience Herbal Api Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 64.3% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phytoscience Herbal Api?
Unlock access to Phytoscience Herbal Api's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Phyto Life Sciences Private LimitedActive 17 years 3 monthsHemaliben Shah, Gaurang Shah and 1 more are mutual person
Phyto Natural Elements Private LimitedActive 6 years 1 monthHemaliben Shah, Gaurang Shah and 1 more are mutual person
- Phyto Concentrates Private LimitedActive 6 years 1 month
Hemaliben Shah and Kalpeshkumar Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Phytoscience Herbal Api?
Unlock and access historical data on people associated with Phytoscience Herbal Api, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phytoscience Herbal Api, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phytoscience Herbal Api's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
